Monthly Archives: January 2020
YS is a 79-year-old female with a medical history of osteoarthritis, insomnia, CVD, GERD, constipation, dementia, and falls. Her current medication list includes donepezil, Senna-S, lisinopril, zolpidem, amitriptyline, baby aspirin, acetaminophen, and omeprazole. Over the last three months, she has had a total of 7 falls and one that resulted in a fractured wrist. Because […]
Read More
I recently received a text from a friend about the use of oral semaglutide in a patient with diabetes. It is definitely exciting to have more options for patients, even though we know there will inevitably be insurance coverage hurdles to jump through. Here are a few things that you should remember about this first […]
Read More
Oftentimes there are numerous agents within a class of medication. Ropinirole (Requip) and pramipexole (Mirapex) is an example of this. When comparing ropinirole and pramipexole, there are clinical differences that might alter which one you choose. Comparing Ropinirole and Pramipexole Pharmacokinetics The most obvious difference when comparing ropinirole and pramipexole involves pharmacokinetic differences. The two […]
Read More
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this switch to generic apixaban availability as well as the recent 2019 atrial fibrillation […]
Read More
2020 Pharmacist Provider Status is being considered by the Trump administration. This is a good thing for the profession and more importantly, a good thing for patients. There were a couple of quotes from CMS Administrator Seema Verma with regards to provider status that really demonstrates that it could be on the way. Here are […]
Read More